Non‐selective beta‐blockers may reduce risk of hepatocellular carcinoma: a meta‐analysis of randomized trials

E-ISSN： 1478-3231|35|8|2009-2016

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.8, 2015-08, pp. : 2009-2016

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials

By Monami Matteo Filippi Luca Ungar Andrea Sgrilli Federica Antenore Alessandro Dicembrini Ilaria Bagnoli Paola Marchionni Niccolò Rotella Carlo Maria Mannucci Edoardo

Current Medical Research and Opinion, Vol. 29, Iss. 4, 2013-04 ,pp. : 369-378

Informa Healthcare

Access to resources Recommend Favorite

Clinical impact of selective and nonselective beta‐blockers on survival in patients with ovarian cancer

CANCER, Vol. 121, Iss. 19, 2015-10 ,pp. : 3444-3451

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment Efficacy Differences of Sorafenib for Advanced Hepatocellular Carcinoma: A Meta-Analysis of Randomized Clinical Trials

Oncology, Vol. 88, Iss. 6, 2015-0 ,pp. : 345-352

Karger

Access to resources Recommend Favorite

Effect of Angiotensin Receptor Blockers on Flow-Mediated Vasodilation: A Meta-Analysis of Randomized Controlled Trials

Cardiology, Vol. 131, Iss. 2, 2015-04 ,pp. : 69-79

Karger

Access to resources Recommend Favorite

Does self-monitoring reduce blood pressure? Meta-analysis with meta-regression of randomized controlled trials

By Bray Emma P. Holder Roger Mant Jonathan McManus Richard J.

Annals of Medicine, Vol. 42, Iss. 5, 2010-07 ,pp. : 371-386

Informa Healthcare

Access to resources Recommend Favorite